The advantageous expression of MARCKS in cancer stroma was further confirmed in another two stoma profiling datasets of lung and prostate cancer and in tumor stroma of EOC patient samples (Figure 1B and 1C). This evidence concerns the gene MARCKS and prostate carcinoma.